Suburban Research Associates

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Depression3 trials
• Obesity3 trials
• High blood pressure2 trials
• Chronic kidney disease1 trial
• Cushing's syndrome1 trial
• Diabetic neuropathy1 trial
• Type 1 diabetes1 trial

Phase

• Phase 27 trials
• Phase 36 trials

Status

• Recruiting8 trials
• Completed3 trials
• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Eli Lilly and Company6 trials
• Boehringer Ingelheim1 trial
• Jazz Pharmaceuticals1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Regeneron Pharmaceuticals1 trial
• and 3 more

Running trials

• Recruiting

  A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  NCT07783802· Phase 2· Eli Lilly and Company· Source

  Contact: Omer Abdullah (principal investigator)

• Recruiting

  A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  NCT07794579· Phase 3· Eli Lilly and Company· Source

  Contact: Omer Abdullah (principal investigator)

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· Phase 3· Eli Lilly and Company· Source

  Contact: Omer Abdullah (principal investigator)

• Recruiting

  An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

  NCT07456696· Phase 3· Transcend Therapeutics· Source

  Contact: Head of Site Operations

• Recruiting

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· Phase 3· Eli Lilly and Company· Source

  Contact: Omer Abdullah (principal investigator)

• Recruiting

  Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  NCT07271186· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  NCT07296484· Phase 2· Sparrow Pharmaceuticals· Source

  Contact: Tom Manager

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06914895· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes4 recruiting
• Depression2 recruiting
• High blood pressure2 recruiting
• Obesity2 recruiting
• Chronic kidney disease1 recruiting
• Cushing's syndrome1 recruiting

Closed trials

• Recruiting

  RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

  NCT07489651· Phase 2· Reunion Neuroscience Inc· Source

  Contact: Mark Pollack Chief Medical Officer, M.D.

• Completed

  A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

  NCT06074562· Phase 2· Eli Lilly and Company· Source

• Completed

  A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

  NCT05593029· Phase 2· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  A Study of JZP150 in Adults With Posttraumatic Stress Disorder

  NCT05178316· Phase 2· Jazz Pharmaceuticals· Source